R B Belshe

Cost-effectiveness analysis of an intranasal influenza vaccine for the prevention of influenza in healthy children.

Lihan K. Yan, B R Luce, B. Luce, 2001, Pediatrics.

Recovery of drug-resistant influenza A virus during therapeutic use of rimantadine

F. Hayden, R. Belshe, A. Hay, 1991, Antimicrobial Agents and Chemotherapy.

Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection

C B Hall, R. Betts, R. Belshe, 1988, Journal of virology.

Immunization of infants and young children with live attenuated trivalent cold-recombinant influenza A H1N1, H3N2, and B vaccine.

E L Anderson, H. Maassab, F. Newman, 1992, The Journal of infectious diseases.

Estimation of the efficacy of live, attenuated influenza vaccine from a two-year, multi-center vaccine trial: implications for influenza epidemic control.

M E Halloran, I M Longini, A. Nizam, 2000, Vaccine.

Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.

J. Mascola, D. Burke, M. McElrath, 1996, The Journal of infectious diseases.